Covered recipient · General Payments record
ROBERT B TAYLOR
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$2,291.06
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,010.91 | 42 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $114.52 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $100.78 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $83.31 | 2 |
| Teleflex LLC | $76.07 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $69.17 | 3 |
| Acerta Pharma LLC | $67.02 | 3 |
| PFIZER INC. | $60.13 | 3 |
| Myriad Genetic Laboratories, Inc. | $41.60 | 2 |
| Janssen Biotech, Inc. | $39.70 | 2 |
| Axonics Modulation Technologies, Inc. | $39.70 | 1 |
| Pharmacosmos Therapeutics Inc. | $35.28 | 2 |
| Novocure Inc. | $27.64 | 2 |
| Incyte Corporation | $25.91 | 1 |
| Astellas Pharma US Inc | $24.10 | 1 |
| Ipsen Biopharmaceuticals, Inc | $22.62 | 1 |
| Gilead Sciences, Inc. | $21.12 | 1 |
| Dendreon Pharmaceuticals LLC | $21.09 | 1 |
| Genmab U.S., Inc. | $18.45 | 1 |
| SOBI, INC | $18.41 | 1 |
| Stemline Therapeutics Inc. | $16.35 | 1 |
| Karyopharm Therapeutics Inc. | $15.68 | 1 |
| EISAI INC. | $15.04 | 1 |
| Merck Sharp & Dohme Corporation | $14.84 | 1 |
| Rigel Pharmaceuticals, Inc. | $14.68 | 1 |
| ADC Therapeutics America, Inc. | $14.32 | 1 |
| JAZZ PHARMACEUTICALS INC. | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.